---
schema_version: "secwatch.filing_event.v1"
accession: "0001785530-21-000043"
form_type: "8-K"
ticker: "HOWL"
cik: "0001785530"
company_name: "Werewolf Therapeutics, Inc."
filed_at: "2021-10-28T23:59:59+00:00"
generated_at: "2026-06-28T16:55:23.487590+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Werewolf Therapeutics appoints Meeta Chatterjee, Ph.D. to Board

## Summary
- Dr. Chatterjee appointed as Class II director, term until 2023 annual meeting.
- She is Senior VP of Global Business Development at Legend Biotech; previously at Merck.
- Receives $35,000 annual cash, $4,000 committee retainer, plus option grant of 23,200 shares at $15.97.
- Appointed to Nominating and Corporate Governance Committee.

## SEC filing metadata
- accession: 0001785530-21-000043
- form_type: 8-K
- ticker: HOWL
- cik: 0001785530
- company_name: Werewolf Therapeutics, Inc.
- filed_at: 2021-10-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1785530/000178553021000043/0001785530-21-000043-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1785530/000178553021000043/howl-20211028.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001785530-21-000043
- JSON: https://secwatch.observer/filing/0001785530-21-000043.json
- Plain text: https://secwatch.observer/filing/0001785530-21-000043.txt

## Key facts
- Executive change
  Meeta Chatterjee, Ph.D. was appointed as Director at Werewolf Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On October 28, 2021, the Board of Directors (the “Board”) of Werewolf Therapeutics, Inc. (the “Company”), upon recommendation of the Board’s Nominating and Corporate Governance Committee, appointed Meeta Chatterjee, Ph.D., as a director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1785530/000178553021000043/0001785530-21-000043-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.